VTx-002
Asset
Delivers a vectorized antibody targeting pathological TDP-43 to promote its clearance.
- Stage
- Phase 2
- Modality
- Gene therapy
- Target
- TARDBP
- 1
- Indication
- 1
- Trial
- 2
- Developers
Indications
1Amyotrophic lateral sclerosis
Phase 2, longevity.technology, Oct 19, 2026
In the full profile
- Target and mechanism1
- Owner and partners2
- Trials1
- Evidence for its targets1
- Competitors1
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.